|

Parkinson's Disease Clinical Trials in Arizona

12 recruiting studies across 3 cities

Browse by City

Mesa
10 trials
Phoenix
10 trials
Tucson
2 trials

All Trials in Arizona

Phase
Trial Phase Dist.
Parkinson's Foundation PD GENEration Genetic Registry—<1 mi
Lenrispodun as Adjunctive Therapy in the Treatment of Patients With Motor Fluctuations Due to Parkinson's DiseasePhase 2<1 mi
PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort—<1 mi
To Evaluate the Efficacy of CVN424 in Parkinson's Disease Participants With Motor ComplicationsPhase 3<1 mi
A Study of CREXONT (Carbidopa and Levodopa) Extended-Release Capsules in Participants With Parkinson's DiseasePhase 4<1 mi
Pimavanserin vs. Quetiapine for Treatment of Parkinson's PsychosisPhase 43 mi
A Study to Assess Safety and Efficacy of Surgical Implant of RNDP-001 in Patients With Idiopathic Parkinson's DiseasePhase 1/23 mi
Phase 1/2a Clinical Trial of PR001 (LY3884961) in Patients With Parkinson's Disease With at Least One GBA1 Mutation (PROPEL)Phase 1/28 mi
Analysis of Cutaneous Phosphorylated Alpha-Synuclein to Identify Patients at Risk of Progressing From Essential Tremor to Parkinson's Disease—8 mi
A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's DiseasePhase 215 mi
Real-World Study of ABBV-951 Subcutaneous Infusion to Assess Change in Disease Activity in Adult Participants With Parkinson's Disease—15 mi
A Study of Buntanetap in Participants With PDPhase 2/315 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.